SEC Company Response from DermTech, Inc. (DMTKQ) (CIK 0001651944) — Sep 15, 2020
DermTech, Inc. (DMTKQ) (CIK 0001651944)
Date: Sept. 15, 2020 · CIK: 0001651944 · Accession: 0001564590-20-043564
AI Filing Summary & Sentiment
File numbers found in text: 333-248657
Letter
dmtk-corresp.DOCX.htm
DERMTECH, iNC.
11099 N. Torrey Pines Road, Suite 100
La Jolla, CA 92037
September 15, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
RE:
DermTech, Inc.
Registration Statement on Form S-3
Filed September 8, 2020
File No. 333-248657
Request for Acceleration
Ladies and Gentlemen:
With respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of DermTech, Inc. (the “Company”), that the Securities and Exchange Commission accelerate the effective date of the Registration Statement to Thursday, September 17, 2020, at 4:15 p.m. Eastern Time, or as soon as practicable thereafter.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Please call Jeremy Glaser or Peter N. Cunningham of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (858) 314-1515 or (617) 348‑1650, respectively, with any comments or questions regarding the Registration Statement.
Very truly yours,
DermTech, Inc.
Show Raw Text
CORRESP 1 filename1.htm dmtk-corresp.DOCX.htm DERMTECH, iNC. 11099 N. Torrey Pines Road, Suite 100 La Jolla, CA 92037 September 15, 2020 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 RE: DermTech, Inc. Registration Statement on Form S-3 Filed September 8, 2020 File No. 333-248657 Request for Acceleration Ladies and Gentlemen: With respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of DermTech, Inc. (the “Company”), that the Securities and Exchange Commission accelerate the effective date of the Registration Statement to Thursday, September 17, 2020, at 4:15 p.m. Eastern Time, or as soon as practicable thereafter. The cooperation of the staff in meeting the timetable described above is very much appreciated. Please call Jeremy Glaser or Peter N. Cunningham of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (858) 314-1515 or (617) 348‑1650, respectively, with any comments or questions regarding the Registration Statement. Very truly yours, DermTech, Inc. /s/ Kevin Sun Kevin Sun Chief Financial Officer cc: Jeremy Glaser, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Peter N. Cunningham, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.